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Abstract
Background—Phenols interact with nuclear receptors implicated in growth and adipogenesis 
regulation. Only a few studies have explored their effects on growth in humans.
Objectives—We studied the associations of maternal exposure to phenols during pregnancy with 
prenatal and postnatal growth of male newborns.
Methods—Within a cohort of women recruited during pregnancy, we selected 520 mother–son 
pairs and quantified 9 phenols in spot urine samples collected during pregnancy. We used 
ultrasonography during pregnancy, together with birth measurements, to assess fetal growth. We 
modeled individual postnatal growth trajectories from repeated measures of weight and height in 
the first 3 years of life.
Results—Triclosan concentration was negatively associated with growth parameters measured at 
the third ultrasound examination but not earlier in pregnancy. At birth, this phenol tended to be 
negatively associated with head circumference (−1.2 mm for an interquartile range [IQR] increase 
in ln-transformed triclosan concentration [95% confidence interval = −2.6 to 0.3]) but not with 
weight or height. Parabens were positively associated with weight at birth. This positive 
association remained for 3 years for methylparaben (β = 193 g [−4 to 389]) for an IQR increase in 
ln-transformed concentrations.
Conclusion—We relied on only 1 spot urine sample to assess exposure; because of the high 
variability in phenol urinary concentrations reported during pregnancy, using only 1 sample may 
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result in exposure misclassification, in particular for bisphenol A. Our study suggested 
associations between prenatal exposure to parabens and triclosan and prenatal or early postnatal 
growth.
Phenolic compounds are used in common products such as solar filters (benzophenone-3), 
cosmetics (parabens), antibacterial soaps (triclosan), and polycarbonate plastics or epoxy 
resins used in can linings (bisphenol A). Precursors of dichlorophenols are used in indoor 
deodorizers and mothballs. Some of these chemicals are known to be endocrine disruptors 
and to interact with nuclear receptors involved in the control of adipogenesis and weight 
gain, such as glucocorticoid, estrogen, and thyroid receptors.1
In vitro studies have reported adipogenic effects for bisphenol A2,3 and parabens.4,5 In 
rodents, perinatal exposure to bisphenol A (doses of 0.25–100 µg/kg of body weight/day) 
has been associated with increased weight at birth and during early life.6–8 There are reports 
of reduced body weight at birth, but at high exposure levels (300 and 1000 mg/kg).9
The human literature is mixed. Some epidemiologic studies are in line with the toxicological 
results, with positive associations between prenatal exposure to bisphenol A and birth 
weight,10 waist circumference, body mass index (BMI), and the risk of being overweight at 
4 years.11 However, there are also negative associations.12,13 Prenatal exposure to bisphenol 
A was negatively associated with fetal weight and head circumference, determined from 
ultrasound measurements.12 The associations were observed only in the offspring of 80 
women for whom 3 measurements of bisphenol A urinary concentrations during pregnancy 
were used to assess exposure; no association was observed when only 1 (n = 219) or 2 (n = 
120) samples were used. This, together with studies showing high within-subject variability 
in phenol urinary concentrations,14 highlights the potential impact of measurement error in 
studies of bisphenol A effects relying on only 1 urine sample, although selection effects 
cannot be ruled out as an explanation of the variations in effect estimates.12 Decreased BMI 
at the age of 9 years in girls, but not boys, has been observed in association with prenatal 
exposure to bisphenol A.13
Data are sparse regarding effects of the other phenols on prenatal and postnatal weight. In a 
preliminary study, among a subsample of 191 male newborns from the French Eden 
mother–child cohort, we observed a negative association between 2,4- and 2,5-
dichlorophenol and birth weight and a positive association between benzophenone-3 and 
birth weight.15 These results were in agreement with another publication concerning male 
newborns from New York City.10 No study has explored the effects of these phenols on 
postnatal growth, nor simultaneously considered the growth continuum from conception 
until childhood.
The objective of this study was to explore the associations between phenol exposures during 
pregnancy and offspring growth from mid-pregnancy until 3 years of age in boys.
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METHODS
Population
The study population is a subgroup of the French EDEN mother–child cohort, which 
consisted of 2002 pregnant women recruited before the end of the 28th gestational week 
from the maternity wards of Poitiers and Nancy University hospitals (France) between April 
2003 and March 2006. Exclusion criteria were personal history of diabetes, multiple fetuses, 
intention to deliver outside the university hospital or to move out of the study region within 
the next 3 years, and inability to speak French. Among the 2002 recruited women, 1899 
gave birth to a singleton live birth, for whom we collected birth weight (eFigure 1, http://
links.lww.com/EDE/A801). We restricted the present analysis to boys (n = 998), with at 
least 1 maternal urine sample available for phenol measurements (n = 983) and complete 
data on prenatal (3 ultrasound measurements and biometry at birth, n = 779) and postnatal 
growth (≥4 measurements of weight and height within the first 3 years of life and present at 
the 3 years clinical exam), for a final sample size of 520 mother–child pairs. Our choice to 
focus on 1 sex was motivated by the fact that, in the context where sex-specific effects of 
exposures are expected,10,13 a study restricted to 1 sex likely has a higher statistical power 
than a study including both sexes in which 2 sex-specific analyses, with half of the initial 
sample size, are conducted.
The EDEN cohort received approval from the ethics committee of Kremlin-Bicêtre 
University hospital. The involvement of the Centers for Disease Control and Prevention 
(CDC) did not constitute engagement in human subject research. The participants gave 
informed written consent for themselves and for their child to be part of the cohort.
Growth Assessments
We assessed biparietal diameter by ultrasound during pregnancy at on average 12.6 
gestational weeks (12 weeks, 4.2 days) (5th–95th centiles = 11.1–14.0), 22.5 gestational 
weeks (20.7–24.4), and 32.6 gestational weeks (30.6–34.2). The other measures of fetal size 
(head circumference, abdominal circumference, and femur length) were assessed only 
during the 2 last ultrasound examinations.16 We estimated fetal weight using the formula 
from Hadlock et al17: log (fetal weight) = 1.3596 - (0.00386 × abdominal circumference × 
femur length) + (0.0064 × head circumference) + (0.00061 × biparietal diameter × 
abdominal circumference) + (0.0424 × abdominal circumference) + (0.174 × femur length). 
Weight and length at birth were extracted from hospital maternity records. Infants were 
weighed and measured at 1 and 3 years during standardized study-specific examinations. 
Additionally, at 4, 8, 12, 24, and 36 months, mothers mailed questionnaires with the boys’ 
weight and height measures, as recorded in the child health booklet by health care 
practitioners.
We used the Jenss nonlinear model to individually model child growth and predict weight 
and height at 6, 12, 24, and 36 months.18 This model provided very good fit to the 
observations in the EDEN cohort (eFigure 2, http://links.lww.com/EDE/A801) and was 
meant to provide a height and weight estimate at exactly the same age for all subjects.19 
Head circumference was assessed in duplicate within 4 days after birth and at 3 years; we 
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used the average of the 2 measures at each age. Because head circumference could be 
distorted by the labor of giving birth, we preferred to use the measures of head 
circumference performed a few days after birth rather than at birth. At 3 years, children’s 
abdominal circumference was measured in duplicate and averaged. We computed average 
growth rates between 2 successive measurements as growth rate = (measurement at t2 − 
measurement at t1)/(t2 − t1).
Biological Sampling and Exposure Assessments
Urine samples were collected between 22 and 29 gestational weeks. Women were asked to 
collect the first morning urine at home before the hospital study visit. If forgotten, the urine 
sample was collected at the hospital during the prenatal study visit. Urine samples were 
aliquoted and stored at −80°C. Measurements of 2,4- and 2,5-dichlorophenol, bisphenol A, 
benzophenone-3, triclosan, methyl-, ethyl-, propyl-, and butylparabens,20 and creatinine 
were performed at the Centers for Disease Control and Prevention (CDC) in Atlanta, GA. 
Depending on the phenol biomarkers, the coefficients of variation of about 60 replicates in a 
period of 9 months were between 3% and 10% at concentrations ranging from around 2 to 
70 ng/ml. Total paraben concentration (∑PB) was calculated by summing molar 
concentrations of the 4 parabens.
Sample shipments to CDC and phenol measurements were performed during 2 periods. 
Among the 191 male newborns in our previous study that assessed the associations of 
phenols with male genital anomalies and birth outcomes (weight, height, head 
circumference),15,21 110 matched the inclusion criteria of the present study and were 
considered here. Their urine samples were analyzed for phenols in 2008. In 2011, we 
extended phenol measurements to the remaining 410 women matching the inclusion criteria 
(eFigure 1, http://links.lww.com/EDE/A801). Year of analysis was taken into account in 
statistical analyses (see below). The laboratory used the same analytic methodology to 
analyze all samples.
Statistical Methods
For phenol biomarker concentrations below the limit of detection, we used instrumental 
reading values. To allow ln-transformation, instrumental reading values equal to 0 (ie, 
indicative of no signal) were replaced by the lowest instrumental reading value divided by 
the square root of 2. Concentrations were standardized for collection conditions: we first 
studied associations between each ln-transformed phenol concentration, sampling conditions 
(hour of sampling, gestational age at collection, duration of storage at room temperature 
before freezing, day of sampling, and creatinine concentrations), and analysis year (2008 or 
2011) using phenol-specific adjusted linear regression models. We used the measured 
urinary bio-marker concentrations and the estimated effects of collection conditions on the 
measured urine concentrations (for conditions associated with urine concentrations with P < 
0.2) to predict standardized concentrations, that is, concentrations that would have been 
observed if all samples had been collected under the same conditions.22 This approach was 
used with the aim of reducing variability in biomarker urinary concentrations due to 
heterogeneity in sampling conditions. Unless otherwise specified, all reported concentrations 
are the standardized values.
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We performed cross-sectional analyses to study the associations between phenol 
concentrations, growth parameters measured at birth, and growth rates. We used linear 
regression models with a random effect variable corresponding to the mother–son pair,23 to 
study the associations between phenol concentrations and growth parameters measured by 
ultrasound examinations during pregnancy and predicted during childhood. To allow for 
effect-measure modifications throughout pregnancy, we included interaction terms between 
phenol concentration and gestational age at outcome measurement (third-order polynomial) 
estimated using the date of last menstrual period (LMP), or gestational duration assessed by 
the obstetrician if it differed from the LMP-based estimate by more than 2 weeks.15
Models for prenatal and postnatal growth were adjusted for maternal and paternal height 
(continuous) and pre-pregnancy weight (continuous), maternal active (continuous) and 
passive (yes/no) smoking during pregnancy, maternal education level (high school or less, 
up to 2 years after high school, ≥3 years after high school), recruitment center, and parity. 
The model for head circumference was additionally adjusted for the number of days between 
birth and the assessment of head circumference. Analyses of postnatal growth were 
additionally adjusted for breastfeeding duration (never, ≤3 months, >3 months). Crude 
analyses are reported in eTable 1 (http://links.lww.com/EDE/A801).
The effect estimates are reported for an increase by 1 interquartile range (IQR) of ln-
transformed phenol standardized concentrations. Analyses in tertiles were conducted but are 
not reported.
Sensitivity Analyses
In sensitivity analyses, models for postnatal weight were additionally adjusted for the 
following: (1) birth weight, which is a potential intermediate factor in the pathway between 
prenatal exposures and postnatal growth and was therefore not controlled for in main 
analyses; (2) height predicted at the same age, to study the association with body mass; and 
(3) child caloric intake at 4 or 8 months for models of weight at 6 or 12 months and more, 
respectively. Caloric intake was computed based on 3-day dietary records at 4 and 8 months. 
We ran models of head circumference based on the measurement performed at birth instead 
of a few days after birth. For all outcomes, we performed sensitivity analyses excluding 
women with pregnancy-induced hypertension (n = 25) or gestational diabetes (n = 28), using 
biomarker concentrations not standardized for sampling conditions rather than the 
standardized values, and using the actual postnatal growth measurements rather than the 
values predicted by the Jenss model.
RESULTS
Population
Average maternal age was 29.7 years; most women (87%) did not smoke during pregnancy, 
26% were overweight or obese (BMI > 25 kg/m2). Twenty-three of the boys (4%) were born 
before 37 gestational weeks and 11 (2%) had a birth weight below 2500 g (Table 1). Women 
in the present study were similar to all Eden women who delivered a boy, except for active 
and passive smoking, which were less frequent in the present study (Table 1). The 
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proportion of newborns with congenital abnormalities among the subsample of 520 boys of 
the study population (5.2%) was similar to those observed among boys of the whole EDEN 
cohort (4.8%).
Exposure
Among the 397 women reporting the hour of urine collection, 268 (68%) collected their 
urine before 8 am, 96 (24%) between 8 and 10 am, 30 (8%) between 10 am and 12 pm, and 
3 (1%) after 12 pm. We detected 6 of the 9 target phenols in at least 93% of the samples 
(Table 2). Relative changes in the median concentration of urinary biomarkers between the 
samples analyzed in 2008 and 2011 varied between −14% (triclosan) and +22% 
(methylparaben).
Association Between Phenols and Growth Parameters
We observed negative associations between (ln-transformed) triclosan concentrations and all 
of the anthropometric and growth parameters measured at the third ultrasound examination, 
but not earlier in pregnancy (Table 3). At birth, triclosan concentration tended to be 
negatively associated with head circumference (−1.2 mm for an IQR increase in ln-
transformed triclosan concentration [95% confidence interval (CI) = −2.6 to 0.3]) but not 
with weight (4.6 g [−49 to 58]) or height (−0.2 mm [−2.6 to 2.3]). Regarding prenatal 
growth rate, triclosan concentration was negatively associated with biparietal diameter 
growth between the first and second ultrasound examinations (−0.03 mm/week [−0.07 to 
0.00]) and with weight growth between the second and third ultrasound examinations (−3.3 
g/week [−6.1 to −0.4]) and positively with weight growth between the third ultrasound 
examination and birth (7.0 g/week [0.3 to 14], Table 4). Triclosan concentration was not 
clearly associated with size parameters measured after birth (Table 3).
Concentrations of all parabens, as well as their sum, tended to be positively associated with 
weight growth between the third ultrasound examination and birth (Table 4) and with weight 
at birth, but not with estimated fetal weight at the second and third ultrasound examinations 
(Table 3). Methylparaben were also positively associated with weight and abdominal 
circumference at 36 months (Table 3, Figure). Regarding postnatal growth rate, parabens 
tended to be positively associated with average weight growth between 12 and 24 months 
and between 24 and 36 months, but not before 12 months (Table 4). The positive 
associations between methylparaben and postnatal weight remained after adjustment for 
child caloric intake and weakened after adjustment for birth weight (eTable 2, http://
links.lww.com/EDE/A801) or height (eTable 3, http://links.lww.com/EDE/A801).
We did not observe clear associations between bisphenol A and any of the prenatal and 
postnatal measurements (Table 3). After adjustment for height, bisphenol A was not 
associated with weight either at birth or at 6 months but tended to be positively associated 
with weight at 12, 24, and 36 months (eTable 3, http://links.lww.com/EDE/A801). The 
effect estimates were 47 g (95% CI = −45 to 138), 76 g (−37 to 190), and 72 g (−67 to 211) 
at 12, 24, and 36 months, respectively, compared with 23 g (−92 to 139), 38 g (−108 to 184), 
and 35 g (−145 to 214) in the analysis not adjusted for child height. Additional adjustment 
for child caloric intake did not change these effect estimates (data not shown).
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2,4-dichlorophenol was negatively associated with abdominal circumference at the third 
ultrasound examination (−1.2 mm [−2.5 to 0.1]) and positively with this outcome recorded 
at 36 months (2.3 mm [−0.2 to 4.9], Table 3). This phenol was positively associated with 
weight growth between 24 and 36 months (0.9 g/weeks [0.1 to 1.8]) but not with weight 
measured at 36 months (38 g [−107 to 183]). We also observed a positive association 
between 2,5-dichlorophenol and head circumference at the third ultrasound examination (1.2 
mm [0.0 to 2.3]).
We did not observe clear associations between benzophenone-3 and the studied growth 
parameters (Table 3). When we used head circumference at birth rather than a few days after 
birth, a positive association with benzophenone-3 was observed (1.0 mm [−0.2 to 2.3]), 
which was not suggested with the measure shortly after birth (0.3 mm [−0.6 to 1.3]).
Our conclusions were not changed by excluding women with pregnancy-induced 
hypertension or gestational diabetes or by using the nonstandardized phenol concentrations 
(eTable 4, http://links.lww.com/EDE/A801) or the actual postnatal growth measures rather 
than the values predicted by the Jenss growth model.
DISCUSSION
Within our population of male newborns, maternal urinary triclosan concentration was 
associated with reduced fetal growth measurements late in pregnancy and with reduced head 
circumference at birth. Parabens were associated with increased weight at birth but not with 
estimated fetal weight during pregnancy. The positive association of methylparaben with 
weight remained until 36 months.
Our study is the first to explore the effects of early-life exposure to phenols on growth from 
early pregnancy until childhood. Strengths of our study are the prospective design (with 
exposure assessment during the biologically relevant fetal period) and the use of repeated 
measurements of growth during fetal and early postnatal life. The sample size is larger than 
in previous studies.10,12,15 In our study population, about two-thirds of women collected 
their urine sample before 8 am, which is likely to correspond to the first morning void. 
Pooled urine samples are expected to provide a better estimate of exposure than spot urine 
samples, but if spot urine samples are to be used, then there is no reason to consider that the 
first morning void is better than other spot samples. Given their short half-life and the 
temporal variations in exposure, hour of urine sampling is likely to influence phenol 
biomarker urinary concentrations,24 and between-subject variations in urine sampling hour 
constitutes an undesirable source of variability in biomarker concentrations.
In order to reduce this variability, we used a 2-step standardization method based on 
regression residuals.22 This approach corrects each biomarker’s concentration so as to obtain 
an estimate closer to what would be expected if all women had collected their urine at the 
same hour. Because this approach is not common, we repeated our analyses using 
concentrations not standardized for sampling conditions and this did not change our 
conclusion.
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Because we used only 1 urine sample to assess phenol concentrations, our results might be 
affected by exposure misclassification, which is a clear limitation, in particular for bisphenol 
A (for which a high within-subject variability in urine concentrations has been reported 
during pregnancy).14,25 Higher reproducibility in urine concentrations has been observed for 
the other phenols (intraclass correlation coefficients ranging between 0.5 and 0.6)14; 
however, even with a correlation of this magnitude, a bias in the dose response is expected. 
Assuming classical type error, the bias in the estimates from linear regression models 
relying on a single urine sample is expected to correspond to an attenuation by a 
multiplicative factor equal to the intraclass correlation coefficient (eg, a 40% decrease in the 
estimated parameter for compounds with an intraclass correlation coefficient of 0.6).26 
Finally, we performed many comparisons and cannot exclude chance findings.
The negative association between triclosan and head circumference at birth is consistent 
with the results obtained in the subsample of 191 male newborns from the EDEN cohort, of 
whom 110 were included in the present analysis.15 Head circumference is a predictor of 
brain volume.27 In animals, triclosan disturbed the homeostasis of thyroid hormones, which 
are required for fetal normal growth and brain development.28,29 In humans, to our 
knowledge, no study has investigated the effects of triclosan exposure on thyroid hormone 
levels during pregnancy.
Maternal urinary concentrations of parabens were associated with higher weight at birth and 
during early childhood. This was explained by an effect on weight growth between the third 
trimester of pregnancy and birth and between 1 and 3 years. In vitro, parabens have 
estrogenic activities30,31; they also promote adipocyte differentiation in murine cells by an 
activation of the glucocorticoid receptor or the peroxisome proliferator-activated receptor 
gamma.4,5 An effect on these nuclear receptors may increase susceptibility to gain weight 
and might play a role in the positive associations observed with abdominal circumference at 
36 months and with postnatal weight. To our knowledge, except for our previous study,15 
which did not find an association between parabens and birth weight (−3 g [95% CI = −39 to 
33]), no other epidemiologic study has explored the associations between these chemicals 
and growth.
A few studies have explored the effect of bisphenol A on fetal growth in humans; both 
positive10,15 and negative12 associations have been reported. We did not observe any 
association between this phenol and fetal growth measurements. However, because we used 
only 1 urine sample to categorize exposure to this chemical, for which urinary 
concentrations show high intra-individual variability, our findings could be affected by 
classical type measurement error, which is expected to strongly bias dose–response 
relationships toward the null.32 Regarding postnatal growth, 1 study has reported a positive 
association between bisphenol A and waist circumference, BMI and the risk of being 
overweight at 4 years, although not earlier in childhood.11 Another study of older children 
did not observe any association with boys’ BMI or waist circumference at the age of 9 
years.13 In our population, after height adjustment, bisphenol A tended to be positively 
associated with weight at 12, 24, and 36 months. The main source of bisphenol A is diet.33 
We cannot exclude the possibility that bisphenol A urinary concentration is a surrogate for 
factors predictive of child overweight, such as maternal and child eating behaviors, which 
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therefore constitute potential confounders. We were limited in our ability to control for 
confounding by eating behaviors because we had only an estimation of the mother and child 
caloric intake, rather than data on the type of food (canned, processed, or fresh) usually 
eaten. In addition, data on food intake were collected by questionnaires, so that our 
estimation is likely to suffer from lack of precision. Adjustment for the child caloric intake 
did not affect the associations of maternal pregnancy bisphenol A concentration with child 
weight, adjusted for height.
The negative associations between dichlorophenols and birth weight observed in our 
previous study15 were not replicated in this study with a larger sample size (520 vs. 191, 
eFigure 3, http://links.lww.com/EDE/A801). Exposure levels did not strongly differ between 
the populations; however, women in the present study were more educated and less likely to 
smoke compared with the 191 women of the previous study; the distribution of unmeasured 
factors confounding the associations between phenols and birth outcomes also could have 
differed across subpopulations. Differences in findings between our 2 studies might also be 
explained by random variations or exposure measurement errors resulting from the use of 1 
urine sample to assess exposure to chemicals with a short half-life.
In conclusion, our study lends support to potential effects of some phenols on prenatal and 
early postnatal growth. However, because of the short half-life of the studied phenols and 
the likely episodic nature of the exposures (in particular bisphenol A), our findings based on 
concentrations of the target biomarkers in a single urine sample may be affected by exposure 
misclassification. Replications are needed in other populations with large sample size and 
improved assessment of exposure to phenols.
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Figure. 
Adjusted associations between maternal urinary concentrations of phenols and weight (A) at 
birth and (B) at the age of 3 years (Eden cohort, 2003–2006, 520 male newborns). Effect 
estimates are given for an increase by 1 IQR of ln-transformed phenol standardized 
concentrations. Adjustment factors for the birth weight analysis: gestational age, maternal 
and paternal height, pre-pregnancy weight, maternal active and passive smoking during 
pregnancy, maternal education level, recruitment center, and parity. Adjustment factors for 
the analysis of weight at 3 years: maternal and paternal height, pre-pregnancy weight, 
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maternal active and passive smoking during pregnancy, maternal education level, 
recruitment center, parity, and breastfeeding duration.
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Table 1
Characteristics of the Study Population (PEnDevE) and Comparisons with the Whole EDEN Cohort 
Delivering Boys
All Male Newborns,
EDEN Cohort (n = 998)a
Women of EDEN Cohort Included in
PEnDevE Study (n = 520)b
Women of EDEN Cohort Include
Gona_PE Study (n = 191)c
Characteristic No. (%) No. (%) No. (%)
Maternal age (years)
    <25 200 (20) 85 (16) 35 (18)
    25–29 378 (38) 200 (38) 71 (37)
    30–34 285 (29) 159 (31) 57 (30)
    ≥35 135 (14) 76 (15) 28 (15)
Parity
    0 436 (44) 248 (48) 72 (38)
    1 374 (37) 192 (37) 75 (39)
    ≥2 187 (19) 79 (15) 44 (23)
    Missing 1 (0) 1 (0)
BMI (kg/m2)
    <18.5 92 (9) 45 (9) 19 (10)
    18.5 to 24.9 634 (64) 331 (64) 115 (60)
    ≥25 251 (25) 137 (26) 54 (28)
    Missing 21 (2) 7 (1) 3 (2)
Maternal education
    <2 years after high school 459 (46) 211 (41) 95 (50)
    High school + 2 years 219 (22) 124 (24) 39 (20)
    ≥High school + 3 years 297 (30) 178 (34) 51 (27)
    Missing 23 (2) 7 (1) 6 (3)
Active smoking (cig/day)d
    0 827 (83) 453 (87) 159 (83)
    1 to 5 82 (8) 39 (8) 15 (8)
    >5 86 (9) 27 (5) 17 (9)
    Missing 3 (0) 1 (0)
Passive smoking
    No 711 (71) 411 (79) 131 (69)
    Yes 278 (28) 108 (21) 59 (31)
    Missing 9 (1) 1 (0) 1 (1)
Center
    Poitiers 533 (53) 312 (60) 91 (48)
    Nancy 465 (47) 208 (40) 100 (52)
Gestational duration
    <37 gestational week 63 (6) 23 (4) 5 (3)
    ≥37 gestational week 935 (94) 497 (96) 186 (97)
Birth weight
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All Male Newborns,
EDEN Cohort (n = 998)a
Women of EDEN Cohort Included in
PEnDevE Study (n = 520)b
Women of EDEN Cohort Include
Gona_PE Study (n = 191)c
Characteristic No. (%) No. (%) No. (%)
    <2500 g 47 (5) 11 (2) 4 (2)
    ≥2500 g 951 (95) 509 (98) 187 (98)
Year of birth
    2003–2004 560 (56) 286 (55) 89 (47)
    2005–2006 438 (44) 234 (45) 102 (53)
Breastfeeding
    Never 270 (27) 135 (26) 51 (27)
    ≤3 months 422 (42) 209 (40) 84 (44)
    >3 months 298 (30) 176 (34) 56 (29)
    Missing 8 (1) 0 (0) 0 (0)
Gona_PE indicates study aiming at studying the associations between phenols, male genital anomalies, and birth outcomes among 191 male 
newborns from the Eden cohort.
aSingleton live births.
bStudy population of this paper
cStudy population of the birth outcome analysis published in 2012.8
dSecond trimester of pregnancy.
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d 
pa
rit
y.
 T
he
 m
od
el
 fo
r h
ea
d 
ci
rc
um
fe
re
nc
e 
at
 b
irt
h 
w
as
 a
dd
iti
on
al
ly
 a
dju
ste
d f
or 
the
 nu
mb
er 
of 
da
ys 
be
tw
een
 bi
rth
 an
d t
he
 as
ses
sm
en
t o
f h
ead
 ci
rcu
mf
ere
nc
e. 
Mo
de
ls 
for
 
po
stn
at
al
 g
ro
w
th
 w
er
e 
ad
jus
ted
 fo
r m
ate
rna
l a
nd
 pa
ter
na
l h
eig
ht,
 pr
e-p
reg
na
nc
y w
eig
ht,
 m
ate
rna
l a
cti
ve
 an
d p
ass
ive
 sm
ok
ing
 du
rin
g p
reg
na
nc
y, 
ma
ter
na
l e
du
cat
ion
 le
ve
l, r
ecr
uit
me
nt 
cen
ter
, b
rea
stf
eed
ing
 
du
ra
tio
n,
 a
nd
 p
ar
ity
.
a
β c
o
rr
es
po
nd
s t
o 
ch
an
ge
s i
n 
gr
ow
th
 ra
te
 (m
m/
we
ek
) e
sti
ma
ted
 fo
r e
ac
h i
nc
rea
se 
by
 1 
IQ
R 
of 
ln-
tra
ns
for
me
d p
he
no
l s
tan
da
rdi
ze
d c
on
ce
ntr
ati
on
s.
b β
 
co
rr
es
po
nd
s t
o 
ch
an
ge
s i
n 
gr
ow
th
 ra
te
 (g
/w
ee
k) 
est
im
ate
d f
or 
ea
ch
 in
cre
ase
 by
 1 
IQ
R 
of 
ln-
tra
ns
for
me
d p
he
no
l s
tan
da
rdi
ze
d c
on
ce
ntr
ati
on
s.
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